Delstrigo and Slow rhr - a phase IV clinical study of FDA data

Summary:

We study 61,392 people who take Delstrigo (doravirine; lamivudine; tenofovir disoproxil fumarate) or have Slow rhr. No report of Slow rhr is found in people who take Delstrigo.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Delstrigo?

Delstrigo has active ingredients of doravirine; lamivudine; tenofovir disoproxil fumarate. eHealthMe is studying from 212 Delstrigo users. Check the latest studies of Delstrigo.

What is Slow Rhr?

Slow rhr is found to be associated with 2,917 drugs and 3,008 conditions by eHealthMe. Check the latest studies of Slow rhr.

On Jun, 17, 2026

No report is found.

Do you take Delstrigo and have Slow rhr?

- Check whether Slow rhr is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Delstrigo:

Delstrigo (212 reports)

Slow rhr treatments and more:

Slow rhr (61,180 reports)

How severe was Slow rhr and when was it recovered:

Slow rhr in Delstrigo

Expand to all the drugs that have ingredients of doravirine; lamivudine; tenofovir disoproxil fumarate:

Slow rhr and drugs with ingredients of doravirine; lamivudine; tenofovir disoproxil fumarate

Browse all side effects of Delstrigo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Slow rhr:

Slow rhr

Browse all the conditions that are associated with Slow rhr:

Slow rhr

How the study uses the data?

The study uses data from the FDA. It is based on doravirine; lamivudine; tenofovir disoproxil fumarate (the active ingredients of Delstrigo) and Delstrigo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.